Here’s What You Need To Know About Pfizer’s COVID Vaccine For Kids Under 12

The US took one step closer toward COVID-19 vaccines for children under 12 after an advisory panel recommended on Tuesday that kids be eligible to get the Pfizer vaccine.

Following a contentious daylong discussion, the panel of outside advisers to the Food and Drug Administration voted 17–0 (with one abstention) to recommend authorizing the two-dose vaccine for kids ages 5 to 11. The group decided that the vaccine’s benefits outweigh the risks and that it is safe and effective for preventing infections.

The approval was based on a study that looked at two 10-microgram doses of the vaccine, one-third the dose given to adults, given three weeks apart. It was more than 90% effective at preventing symptomatic COVID-19 in the study of 2,268 children.